Alpek is back in focus after its fair value estimate shifted from MX$15.08 to MX$16.38, signaling a refreshed price target framework that matters for anyone tracking the stock. Bullish analysts have highlighted price targets ranging from around MX$16 to MX$20.50, and the updated fair value sits close to the lower end of that range. This aligns with the more constructive tone in recent research. As you read on, you will see how these changing targets fit into the broader analyst narrative and what to watch as that story develops.
Stay updated as the Fair Value for ALPEK. de shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on ALPEK. de.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
Both BBVA and Grupo Santander have upgraded Alpek to Outperform in recent months. This signals a more constructive stance on how the company is executing its plans.
-
Grupo Santander set a MX$20.50 price target for Alpek, which sits toward the upper end of recently cited targets and indicates that current pricing may not fully reflect the analysts' assessment of the company.
-
BBVA moved its rating to Outperform with a MX$16 price target, broadly in line with the refreshed fair value estimate around MX$16.38. This supports the idea that recent valuation work is coalescing around a similar range.
🐻 Bearish Takeaways
-
The recent upgrades from BBVA and Grupo Santander follow prior Neutral and Market Perform views. This highlights that analysts have shown caution on Alpek in the past and could reassess again if execution or industry conditions turn less favorable.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 2 risks for ALPEK. de. See which could impact your investment.
How This Changes the Fair Value For ALPEK. de
-
Fair value moved from MX$15.08 to MX$16.38, an increase of about 8.6% in the updated model.
-
Revenue growth was revised from 2.23% to 1.22% in expected MX$ sales growth.
-
Net profit margin shifted from 3.26% to 2.06% as a share of revenue.
-
Future P/E moved from 11.9x to 19.9x in the revised assumptions.
-
Discount rate moved from 17.99% to 17.30%, a change of around 0.7 percentage points in the risk assumption.
Never Miss an Update: Follow The Narrative
Narratives connect Alpek's business story to analyst forecasts and fair value assumptions so you can see how new information feeds into the outlook. They update over time as fresh data and research come through.
Head over to the Simply Wall St Community and follow the Narrative on ALPEK. de to stay up to date on:
-
How new reciprocal PET tariffs into the U.S. and potential shifts in global trade flows could affect Alpek's polyester volumes and earnings mix.
-
The impact of footprint optimization, cost cutting, and a focus on higher return polypropylene and EPS businesses on margins and cash generation.
-
Key risks from global PET oversupply, compressed polyester margins, elevated net debt around US$1.8b, and execution challenges on plant closures and divestitures.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ALPEK-A .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
